FDA approves international phase III study of carrimycin in patients with severe COVID-19 Dec. 24, 2020
Intranasal RECCE-327 and RECCE-529 demonstrate activity against SARS-CoV-2 virus in vivo Dec. 24, 2020
First patients dosed in phase I/II study of SIIPL's COVID-19 vaccine candidate plus CpG-1018 Dec. 24, 2020
RSS